5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EZH2 mutations: Mutating the epigenetic machinery in myeloid malignancies
    Journal Article

    Abdel-Wahab, O.; Levine, R. L.
    Cancer Cell (2010)

    Fulltext@MSK | Save
  • Melanoma-specific targeted therapies
    Book Section

    Chapman, P. B.; Solit, D. B.; Flaherty, K. T.
    In Balch, C. M.; Houghton, A. N.; Sober, A. J.; Soong, S. J.; Atkins, M. B.; Thompson, J. F (Eds.) Cutaneous Melanoma. 5th ed (2009)

    Fulltext@MSK | Save
  • Genomic identification of significant targets in brain cancer
    Book Section

    Beroukhim, R.; Getz, G.; Mellinghoff, I. K.
    In Van Meir, E. G. (Eds.) CNS Cancer: Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches (2009)

    Fulltext@MSK | Save
  • A phase Ib trial of IPI-504 (retaspimycin hydrochloride), a novel Hsp90 inhibitor, in combination with docetaxel
    Meeting Abstract

    Riely, G. J.; Stoller, R.; Egorin, M.; Solit, D.; Dunbar, J.; Savage, A.; Walker, J.; Grayzel, D.; Ross, R.; Weiss, G. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I/II study of docetaxel and (153)Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Rathkopf, D.; Solit, D.; Carrasquillo, J.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies
    Meeting Abstract

    Mitsiades, N.; Schultz, N.; Taylor, B. S.; Hieronymus, H.; Satagopan, J.; Scardino, P. T.; Reuter, V. E.; Sander, C.; Sawyers, C.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Elevated expression of VEGFR-2 and VEGFA in desmoplastic small round cell tumor (DSRCT) and activity of bevacizumab and irinotecan in a xenograft model of DSRCT
    Meeting Abstract

    Magnan, H. D.; Chou, T.; LaQuaglia, M. P.; Gerald, W.; Ladanyi, M.; Merchant, M. S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)
    Meeting Abstract

    Gong, Y.; Yao, E.; Arcila, M.; Frankel, S.; Teruya-Feldstein, J.; Zakowski, M.; Thomas, R.; Ladanyi, M.; Pao, W.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Rebiopsy of patients (pts) with acquired resistance to epidermal growth factor tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Arcila, M. E.; Riely, G. J.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Miller, V. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Efficacy of the novel non-quinone based HSP-90 inhibitor PU-H71 in JAK2V617F and MPLW515L-induced murine models of myeloproliferative neoplasms
    Meeting Abstract

    Koppikar, P.; Marubayashi, S.; Taldone, T.; Abdel-Wahab, O.; West, N.; Gozman, A.; Ahn, J.; Rodina, A.; Bhagwat, N.; Hedvat, C. V.; more...
    Blood (2009)

    Fulltext@MSK | Save